A new wave of research is showing what the old gym myths about stretching got wrong—and what you really need to do to reap its benefits.

A rare Homo habilis skeleton from Kenya reveals how early humans moved, climbed, and adapted more than two million years ago.

Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

The symmetrical design and flexible fingers mean that the robot can transport objects on either side of its body. For humans, ...

A look at Amyotrophic Lateral Sclerosis (ALS), focusing on motor neuron degeneration, sporadic versus familial ...

PIP is broken down into two parts with daily living starting at £73.90 for the lower rate, rising to £110.40 for higher ...

A breakthrough method from the 1990s is now being transformed into an AI-powered tool to help doctors diagnose cerebral palsy ...

If approved, levacetylleucine could become the first therapy on the market for ataxia-telangiectasia.

The DWP has issued a full list of 533 conditions which could qualify you for a £187 a week payment. Personal Independence ...

IntraBio Inc. today announced positive topline results from its pivotal Phase III IB1001-303 clinical trial, "Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Randomized, ...

Six poster presentations highlight CARVYKTI® efficacy, safety, and real-world outcomes across CARTITUDE trials and analyses, ...